Mild cognitive impairment

doi:10.1017/CBO9780511544873.028

27 - Mild cognitive impairment

from Part IV - Alzheimer's disease

Published online by Cambridge University Press: 04 August 2010

M. Flint Beal ,

Anthony E. Lang and

Albert C. Ludolph

Keith A. Josephs ,

David F. Tang-Wai and

Ronald C. Petersen

Show author details

M. Flint Beal: Affiliation:
Cornell University, New York
Anthony E. Lang: Affiliation:
University of Toronto
Albert C. Ludolph: Affiliation:
Universität Ulm, Germany
Keith A. Josephs: Affiliation:
Department of Neurology, Mayo Clinic, Rochester, MN, USA
David F. Tang-Wai: Affiliation:
Division of Neurology, University Health Network, Toronto Western Hospital, ON, Canada
Ronald C. Petersen: Affiliation:
Department of Neurology, Mayo Clinic, Rochester, MN, USA

Book contents

Get access

Summary

Overview

As research in aging and dementia moves toward an earlier identification of individuals with a cognitive impairment, the concept of mild cognitive impairment (MCI) has received considerable attention. Mild cognitive impairment refers to an intermediate stage between the cognitive changes that are felt to be part of normal aging and those that represent the very earliest features of a dementia such as Alzheimer's disease. This stage of intermediate impairment is believed to be important, since several studies have indicated that these subjects are likely to progress to AD at an accelerated rate over the general population (Petersen et al., 1999). The initial literature on the concept of MCI pertained to individuals with memory impairment beyond what would be expected for normal aging (Petersen, 1995). These subjects may have a mild impairment in other cognitive domains but performance is felt to be within the range of normal. Similarly, they may have slight difficulties with activities of daily living, but these are generally felt not to be significant. More recently, the construct of MCI has been broadened to include other presentations of persons with transitional cognitive impairment and these will be discussed below. Implicit in the discussion of MCI is an understanding of the concept of normal cognitive function. While we are learning a great deal about aging and cognitive function, this still remains an area of uncertainty.

Type: Chapter
Information: Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 409 - 415

DOI: https://doi.org/10.1017/CBO9780511544873.028 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Bobinski, M., Leon, M. J., Tarnawski, M.et al. (1998). Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer's disease. Brain Res., 805, 267–9CrossRef Google Scholar

Bobinski, M., Leon, M. J., Convit, A.et al. (1999). MRI of entorhinal cortex in mild Alzheimer's disease. Lancet, 353, 38–40CrossRef Google Scholar PubMed

Buschke, H., Kuslansky, G., Katz, M.et al. (1999). Screening for dementia with the memory impairment screen. Neurology, 52, 231–8CrossRef Google Scholar PubMed

Crook, T., Bartus, R. T., Ferris, S. H., Whitehouse, P., Cohen, G. D. & Gershon, S. (1986). For the National Institute of Mental Health Work Group. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Dev. Neuropsychol., 2, 261–7CrossRef Google Scholar

Kosky, S. T., Ikonomovi, M. D., Styren, S. D.et al. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol., 51, 145–55Google Scholar

Folstein, M. F., Folstein, S. E. & MCHugh, P. R. (1975). ‘Mini-Mental State’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 12, 189–98CrossRef Google Scholar

Galasko, D., Clark, C., Chang, L.et al. (1997). Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology, 48, 632–5CrossRef Google Scholar PubMed

Graff-Radford, N., Lucas, J., Younkin, L. & Younkin, S. (2003). Longitudinal analysis of plasma Aß42 in patients progressing from normal through MCI to AD. Neurology, 60(S1), A245Google Scholar

Graham, J. E., Rockwood, K., Beattie, B. L.et al. (1997). Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet, 349, 1793–6CrossRef Google Scholar

Grundman, M., Petersen, R. C., Ferris, S. H.et al. (2004). Alzheimer's Disease Cooperative Study. Arch. Neurol., 61, 59–66CrossRef Google Scholar

Holman, B. L., Johnson, K. A., Gerada, B., Carvalho, P. A. & Satlin, A. (1992). The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J. Nuc. Med., 33, 181–5Google Scholar PubMed

Ivnik, R. J., Malec, J. F., Smith, G. E.et al. (1992). Mayo's older American normative studies: WAIS-R, WMS-R and AVLT norms for ages 56 through 97. Clin. Neuropsychol., 6(suppl), 1–104CrossRef Google Scholar

Jack, C. R. Jr. (2003). Magnetic resonance imaging. In Mild Cognitive Impairment: Aging to Alzheimer's Disease. ed. R. C. Petersen, pp. 105–32. New York: Oxford University Press, Inc

Jack, C. R. Jr., Petersen, R. C., Xu, Y. C.et al. (1999). Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology, 52, 1397–403CrossRef Google Scholar PubMed

Johnson, K. A. & Albert, M. S. (2000). Perfusion abnormalities in prodromal AD. Neurobiol. Agin., 21, 289–92CrossRef Google Scholar PubMed

Johnson, K. A. & Albert, M. S. (2003). Functional Imaging. In Mild Cognitive Impairment: Aging to Alzheimer's Disease, ed. R. C. Petersen, pp. 133–48. New York: Oxford University Press, Inc

Johnson, K. A., Jones, K. J., Becker, J. A., Satlin, A., Holman, B. L. & Albert, M. S. (1998). Preclinical prediction of Alzheimer's disease using SPECT. Neurology, 50, 1563–71CrossRef Google Scholar PubMed

Kantarci, K., Jack, C. R. Jr., Xu, Y. C.et al. (2000). Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology, 55, 210–17CrossRef Google Scholar PubMed

Kaye, J. A., Oken, B. S., Howieson, D. B., Howieson, J., Holm, L. A. & Dennison, K. (1994). Neurologic evaluation of the optimally healthy oldest old. Arch. Neurol., 51, 1205–11CrossRef Google Scholar PubMed

Killiany, R. J., Gomez-Isla, T., Moss, M.et al. (2000). Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann. Neurol., 47, 430–93.0.CO;2-I>CrossRef Google Scholar PubMed

Knopman, D. S. & Ryberg, S. (1989). A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch. Neurol., 46, 141–5CrossRef Google Scholar PubMed

Kokmen, E., Smith, G. E., Petersen, R. C., Tangalos, E. & Ivnik, R. J. (1991). The short test of mental status: Correlations with standardized psychometric testing. Arch. Neurol., 48, 725–8CrossRef Google Scholar PubMed

Kral, V. A. (1962). Senescent forgetfulness: benign and malignant. Can. Med. Assoc. J., 86, 257–60Google Scholar PubMed

Machulda, M. M., Ward, H. A., Borowski, B.et al. (2003). Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology, 61, 500–6CrossRef Google Scholar PubMed

Masur, D. M., Sliwinski, M., Lipton, R. B., Blau, A. D. & Crystal, H. A. (1994). Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology, 44, 1427–32CrossRef Google Scholar PubMed

Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–14CrossRef Google Scholar PubMed

Newman, S. K., Warrington, E. K., Kennedy, A. M. & Rossor, M. N. (1994). The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. J. Neurol. Neurosurg. Psychiatr., 57, 967–72CrossRef Google Scholar

Orgogozo, J. M., Gilman, S., Dartigues, J. F.et al. (2003). Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology, 61, 46–54CrossRef Google Scholar

Petersen, R. C. (1995). Normal aging, mild cognitive impairment, and early Alzheimer's disease. Neurologist, 1, 326–44Google Scholar

Petersen, R. C. (2002). Mild cognitive impairment. Neurobiol. Agin., 23, S145Google Scholar

Petersen, R. C. (2003a). Mild cognitive impairment clinical trials. Nat. Rev. Drug Discov., 2, 646–53CrossRef Google Scholar

Petersen, R. C. (2003b). Clinical evaluation. In Mild Cognitive Impairment: Aging to Alzheimer's Disease, ed. R. C. Petersen, pp. 229–42. New York: Oxford University Press, Inc

Petersen, R. C. & Morris, J. C. (2003). Clinical features. In Petersen, R. C., ed. Mild Cognitive Impairment: Aging to Alzheimer's Disease, ed. R. C. Petersen, pp. 15–40. New York: Oxford University Press, Inc

Petersen, R. C., Kokmen, E., Tangalos, E., Ivnik, R. J. & Kurland, L. T. (1990). Mayo Clinic Alzheimer's Disease, Patient Registry. Aging, 2, 408–15Google Scholar

Petersen, R. C., Smith, G. E., Ivnik, R. J., Kokmen, E. & Tangalos, E. G. (1994). Memory function in very early Alzheimer's disease. Neurology, 44, 867–72CrossRef Google Scholar PubMed

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol., 56, 303–8CrossRef Google Scholar PubMed

Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L. & DeKosky, S. T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1133–42CrossRef Google Scholar PubMed

Petersen, R. C., Tang-Wai, D. F., Boeve, B. F.et al. (2003). Predictors of mild cognitive impairment. Neurology, 60, A244Google Scholar

Reisberg, B., Ferris, S., deLeon, M. J. & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatr., 139, 1136–9Google Scholar PubMed

Rogers, S. L., Farlow, M. D., Doody, R. S., Mohs, R. & Friedhoff, L. T. (1998). A 24-week, double-blind placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donezepil Study Group. Neurology, 50, 136–45CrossRef Google Scholar

Rowe, J. W. & Kahn, R. L. (1987). Human aging: usual and successful. Science, 237, 143–9CrossRef Google Scholar PubMed

Sliwinski, M., Lipton, R. B., Buschke, H. & Stewart, W. (1996). The effect of pre-clinical dementia on estimates of normal cognitive function in aging. J. Gerontol. Psychol. Sci., 51B, 217–25CrossRef Google Scholar

Smith, G. E., Ivnik, R. J., Malec, J. F., Petersen, R. C., Tangalos, E. G. & Kurland, L. T. (1992). Mayo's older Americans normative studies (MOANS): factors structure of a core battery. Psychol. Assessm.: J. Cons. Clin. Psycholog., 4, 382–90CrossRef Google Scholar

Solomon, P. R., Hirschoff, A., Kelly, B.et al. (1998). A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch. Neurol., 55, 349–55CrossRef Google Scholar PubMed

Storandt, M. & Hill, R. D. (1989). Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. Arch. Neurol., 46, 383–6CrossRef Google Scholar PubMed

Sunderland, T., Wolozin, G. & Galasko, D. (1990). Longitudinal stability of CSF tau levels in Alzheimer patients. Biol. Psychiatr., 46, 750–5CrossRef Google Scholar

Tang-Wai, D. F., Knopman, D. S., Geda, Y. E., et al. (2003). A comparison of the short test of mental status and the mini-mental status examination in determining mild cognitive impairment. Arch. Neurol., 60, 1777–81CrossRef Google Scholar

Waring, S. C., Rocca, W. A., Petersen, R. C., O'Brien, P. C., Tangalos, E. G. & Kokmen, E. (1999). Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology, 52, 965–70CrossRef Google Scholar PubMed

Welsh, K., Butters, N., Hughes, J., Mohs, R. & Heyman, A. (1991). Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch. Neurol., 48, 278–81CrossRef Google Scholar PubMed

Welsh, K., Butters, N., Hughes, J., Mohs, R. & Heyman, A. (1992). Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch. Neurol., 49, 448–52CrossRef Google Scholar PubMed

Xu, Y. C., Jack, C. R., Jr., Petersen, R. C.et al. (2000). Usefulness of MRI measures of entorhinal cortex vs. hippocampus in AD. Neurology, 54, 1760–7CrossRef Google Scholar

Yaffe, K., Sawaya, G., Liebergurg, I. & Grady, D. (1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J. Am. Med. Assoc., 279, 688–95CrossRef Google Scholar PubMed